Noramco, LLC, a North American producer of controlled substance and specialty bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, has reactivated its previously filed Type II Drug Master File (DMF) to the U.S. FDA for the active pharmaceutical ingredient methylnaltrexone bromide. The DMF number is 026528 and the FDA has acknowledged the DMF is again active.   Methylnaltrexone bromide is the active ingredient in Relistor, an FDA-approved prescription medication for th...